Anand P, Springer SA, Copenhaver MM, Altice FL (2010) Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav 14(6):1213–1226
Article PubMed PubMed Central Google Scholar
Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegran H, Howard AA, Schoenbaum EE (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 17(5):377–381
Article PubMed PubMed Central Google Scholar
Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A (2009) Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr 50:93–99
Benton A, Hamsher K, Sivan A (1983) Multilingual aphasia examination, 3rd edn. AJA Associates, Iowa City, IA
Boucoiran I, Albert A, Tulloch K, Wagner EC, Pick N, van Schalkwyk J, Harrigan PR, Money D (2017) Human immunodeficiency virus viral load rebound near delivery in previously suppressed, combination antiretroviral therapy-treated pregnant women. Obstet Gynecol 130(3):497–501. https://doi.org/10.1097/AOG.0000000000002133
Brandt J, Benedict RHB (2001) Hopkins Verbal Learning Test — revised professional manual. Psychological Assessment Resources Inc, Lutz, FL
Burch AE, Rash CJ, Petry NM (2017) Cocaine-using substance abuse treatment patients with and without HIV respond well to contingency management treatment. J Subst Abuse Treat 77:21–25. https://doi.org/10.1016/j.jsat.2017.03.001
Article PubMed PubMed Central Google Scholar
Cai Y, Yang L, Callen S, Buch S (2016) Multiple faceted roles of cocaine in potentiation of HAND. Curr HIV Res 14(5):412–416. https://doi.org/10.2174/1570162x14666160324125158
Article CAS PubMed Google Scholar
Cattie JE, Doyle K, Weber E, Grant I, Woods SP (2012) Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol 34(9):906–918
Article PubMed PubMed Central Google Scholar
Centers for Disease Control and Prevention (2020) Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2018. HIV Surveillance Supplemental Report, 25(2). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed Sept 2021
Cheever LW (2007) Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis 44:1500–1502
Chilunda V, Calderon TM, Martinez-Aguado P, Berman JW (2019) The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Brain Res 1724:146426. https://doi.org/10.1016/j.brainres.2019.146426
Article CAS PubMed PubMed Central Google Scholar
Cisneros IE, Erdenizmenli M, Cunningham KA, Paessler S, Dineley KT (2018) Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. Neuropharmacology 135:431–443. https://doi.org/10.1016/j.neuropharm.2018.03.019
Article CAS PubMed PubMed Central Google Scholar
Diehr MC, Cherner M, Wolfson TJ, Miller SW, Grant I, Heaton RK (2003) The 50 and 100 item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. J Clin Exp Neuropsychol 25:571–585. https://doi.org/10.1076/jcen.25.4.571.13876
Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW (2008) A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 165:179–187
Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP (2019) Ending the HIV Epidemic: a plan for the United States. JAMA 321(9):844–845
First MB, Williams JBW, Karg RS, Spitzer RL (2015) Structured clinical interview for DSM-5—Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV). Arlington, VA: American Psychiatric Association
Foster S, LeFauve C, Kresky-Wolff M, Rickards L (2010) Services and supports for individuals with co-occurring disorders and long-term homelessness. J Behav Health Serv Res 37(2):239–251
Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ (2011) The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52:793–800. https://doi.org/10.1093/cid/ciq243
Article PubMed PubMed Central Google Scholar
Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D (2016) A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS Behav 20(5):1049–1059
Article PubMed PubMed Central Google Scholar
Gates TM, Cysique LA (2016) The chronicity of HIV infection should drive the research strategy of neuroHIV treatment studies: a critical review. Central Nerv Syst Drugs 30(1):53–69
Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR (2004) Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 5(2):74–79
Golden CJ (1978) Stroop Color and Word Test. Stoelting, Chicago, IL
Gott C, Gates T, Dermody N, Brew BJ, Cysique LA (2017) Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. PLoS ONE 12(3):e0171887
Article PubMed PubMed Central Google Scholar
Gwadz M, de Guzman R, Freeman R, Kutnick A, Silverman E, Leonard NR, Ritchie AS, Munoz-Plaza C, Salomon D, Wolfe H, Hilliard C, Cleland CM, Honig S (2016) Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study. Front Public Health 4:62
Article PubMed PubMed Central Google Scholar
Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine M, Woods S, Vaida F, Atkinson J, Marcotte T, McCutchan J, Collier A, Marra C, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, Abransom I, Gamst A, Fennema-Notestine C, Smith D, Grant I (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3):473–480
Article CAS PubMed Google Scholar
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10(3):317–331
Klove H (1963) Grooved Pegboard. Lafayette Instruments, Lafayette, IN
Laverick R, Haddow L, Daskalopoulou M, Lampe F, Gilson R, Speakman A, Rodger A (2017) Self-reported decline in everyday function, cognitive symptoms, and cognitive function in people with HIV. J Acquir Immune Defic Syndr 76(3):e74–e83
Lentz MR, Kim WK, Kim H, Soulas C, Lee V, Venna N, Halpern EF, Rosenberg ES, Williams K, González RG (2011) Alterations in brain metabolism during the first year of HIV infection. J Neurovirol 17(3):220–229. https://doi.org/10.1007/s13365-011-0030-9
Article CAS PubMed PubMed Central Google Scholar
Lucas GM, Gebo KA, Chaisson RE, Moore RD (2002) Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 16(5):767–774
McLellan AT, Alterman AI, Cacciola J, Metzger D, O’Brien CP (1992) A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis 180(2):101–110
Meade CS, Towe SL, Skalski LM, Robertson KR (2015) Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Drug Alcohol Depend 149:128–135
Article PubMed PubMed Central Google Scholar
Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, del Rio C (2016) Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial. JAMA 316(2):156–170. https://doi.org/10.1001/jama.2016.8914
Article PubMed PubMed Central Google Scholar
Pan Y, Metsch LR, Gooden LK, Philbin MM, Daar ES, Douaihy A, Jacobs P, Del Rio C, Rodriguez AE, Feaster DJ (2019) Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV. Int J STD AIDS 30(9):891–901. https://doi.org/10.1177/0956462419846726
Article CAS PubMed PubMed Central Google Scholar
Parsons JT, Starks TJ, Millar BM, Boonrai K, Marcotte D (2014) Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence. Drug Alcohol Depend 139:33–40
Article PubMed PubMed Central Google Scholar
Phillips J (2020) What you need to know about the 6 EHE indicators: The AHEAD Dashboard. What You Need to Know About the 6 EHE Indicators: The AHEAD Dashboard | HIV.gov
Potvin S, Stavro K, Rizkallah E, Pelletier J (2014) Cocaine and cognition: a systematic quantitative review. J Addict Med 8(5):368–376
Article CAS PubMed Google Scholar
Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD (2016) Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat 61:47–59
Rasbach DA, Desruisseau AJ, Kipp AM, Stinnette S, Kheshti A, Shepherd BE, Qian HZ (2013) Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care 25(1):109–117
Reger M, Welsh R, Razani J, Martin DJ, Boone KB (2002) A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc JINS 8(3):410–424. https://doi.org/10.1017/s1355617702813212
留言 (0)